Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.

Background: Intrathecal baclofen (ITB) is traditionally reserved for non-ambulatory patients.

Objective: To investigate outcomes of ITB in ambulatory multiple sclerosis (MS) patients.

Methods: Changes in outcome measures were estimated by a mixed effect model, while the complication rate was calculated using a logistic regression.

Occlusion of the Ascenda Catheter in a Patient with Pump Twiddler's Sydrome: A Case Report.

Introduction: Intrathecal baclofen (ITB) therapy is an effective way to manage spasticity in numerous conditions, including multiple sclerosis, stroke, and cerebral palsy. While pump failure is a common complication of ITB, improvements in device design have led to reduction of complications. In particular, the Ascenda catheter from Medtronic, Inc.